Timing | Tumor characteristics | Nerve-sparing | Hormone therapy | |||||
---|---|---|---|---|---|---|---|---|
Pearson r p-value | Age at RP | Follow-up duration | Age at follow-up | PSA | T-stage | Gleason score | ||
UF | -0.093 0.075 | -0.091 0.080 | -0.119 0.023 | -0.167 0.001 | -0.139 0.008 | -0.184 0.001 | 0.096 0.066 | -0.131 0.017 |
UB | -0.049 0.348 | -0.079 0.131 | -0.076 0.145 | -0.142 0.006 | -0.163 0.002 | -0.156 0.004 | 0.117 0.025 | -0.105 0.055 |
SF | -0.247 < 0.001 | -0.214 <0.001 | -0.298 <0.001 | -0.111 0.033 | -0.144 0.006 | -0.150 0.006 | 0.272 <0.001 | -0.113 0.039 |
SB | 0.061 0.244 | 0.240 <0.001 | 0.144 0.006 | 0.050 0.338 | -0.180 <0.001 | -0.033 0.552 | 0.162 0.002 | -0.143 0.009 |